Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oulanti Weikang Tablet
- Development stage
- Phase 3
- Lead developer
- Jiangxi Qingfeng Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Oulanti Weikang Tablet (欧兰替胃康片) is a proprietary Traditional Chinese Medicine (TCM) therapeutic developed by Jiangxi Qingfeng Pharmaceutical for the treatment of functional dyspepsia (FD). It is specifically indicated for the postprandial distress syndrome (PDS) subtype, which is characterized by symptoms such as postprandial fullness and early satiety, corresponding to the 'qi stagnation' pattern in TCM theory. As a Class 1.1 new Chinese medicine, it has undergone rigorous clinical testing in China, progressing from Phase II (CTR20191090) to Phase III (CTR20212643) clinical trials. The formulation is designed to regulate gastrointestinal motility and improve visceral sensitivity through a multi-component herbal approach.
- Brand names
- Oulanti Weikang TabletOulanti
- Other names
- 欧兰替胃康片
Beyond the preview
Go deeper on Oulanti Weikang Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oulanti Weikang Tablet.